Carcinoma, Non-Small Cell Lung Clinical Trials in Busan
2 recruitingBusan, South Korea
Showing 1–2 of 2 trials
Recruiting
Phase 3
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Carcinoma, Non-Small Cell Lung
Eli Lilly and Company700 enrolled353 locationsNCT06890598
Recruiting
A Study of Usage of Brigatinib in the Treatment of Adult Participants for Approved Indications In South Korea
Carcinoma, Non-Small Cell LungAnaplastic Lymphoma Kinase
Takeda257 enrolled1 locationNCT04592523